|
| 35976993 | Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine. | Sci Transl Med | 2022 |
| 36311717 | Narcolepsy and H1N1 influenza immunology a decade later: What have we learned? | Frontiers in Immunology | 2022 |
| 36355775 | Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses. | PLoS ONE | 2022 |
| 35606518 | Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice. | NPJ Vaccines | 2022 |
| 34619077 | Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. | Cell | 2021 |
| 34021167 | Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. | npj Vaccines | 2021 |
| 34174187 | The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. | Cell | 2021 |
| 33873199 | Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. | Nature | 2021 |
| 33758839 | Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines. | bioRxiv | 2021 |
| 33594366 | Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates. | bioRxiv | 2021 |
| 33177181 | Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. | Science Translational Medicine | 2020 |
| 32411130 | The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection. | Front Immunol | 2020 |
| 31149870 | Role and plasticity of Th1 and Th17 responses in immunity to . | Human Vaccines and Immunotherapeutics | 2019 |
| 31031030 | Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. | Vaccine | 2019 |
| 30739514 | Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types. | Expert Review of Vaccines | 2019 |
| 30850240 | Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans. | Vaccine | 2019 |
| 29582861 | Erratum: Author Correction: Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity. | npj Vaccines | 2018 |
| 28934066 | Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine. | Human Vaccines and Immunotherapeutics | 2018 |
| 30064669 | Short-term and mid-term solutions for influenza vaccines. | Lancet Infectious Diseases, The | 2018 |
| 29632533 | Adjuvant-Associated Peripheral Blood mRNA Profiles and Kinetics Induced by the Adjuvanted Recombinant Protein Candidate Tuberculosis Vaccine M72/AS01 in Bacillus Calmette-Guérin-Vaccinated Adults. | Frontiers in Immunology | 2018 |
| 27629482 | Evaluation of the potential effects of AS03-adjuvanted A(H1N1)pdm09 vaccine administration on the central nervous system of non-primed and A(H1N1)pdm09-primed cotton rats. | Human Vaccines and Immunotherapeutics | 2017 |
| 28855902 | Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. | Frontiers in Immunology | 2017 |
| 28588574 | Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial. | Frontiers in Immunology | 2017 |
| 28446441 | Long-Term Persistence of Cell-Mediated and Humoral Responses to A(H1N1)pdm09 Influenza Virus Vaccines and the Role of the AS03 Adjuvant System in Adults during Two Randomized Controlled Trials. | Clinical and Vaccine Immunology | 2017 |
| 28193898 | Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. | Proc Natl Acad Sci U S A | 2017 |
| 27849037 | Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination. | Scientific Reports | 2016 |
| 27105343 | Evaluation of potential immunogenicity differences between Pandemrixâ¿¢ and Arepanrixâ¿¢. | Human Vaccines and Immunotherapeutics | 2016 |
| 27236001 | Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. | Clinical Immunology | 2016 |
| 26072017 | Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting. | Vaccine | 2015 |
| 26844287 | Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences. | eBioMedicine | 2015 |
| 25253677 | Retraction of the letter: "Comment on 'CD4⺠T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy' ". | Science Translational Medicine | 2014 |
| 24342916 | Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal. | Human Vaccines and Immunotherapeutics | 2014 |
| 24285844 | Correlate of immune protection against HSV-1 genital disease in vaccinated women. | Journal of Infectious Diseases | 2014 |
| 24864125 | Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study. | Journal of Infectious Diseases | 2014 |
| 25101885 | Seeking help: B cells adapting to flu variability. | Science Translational Medicine | 2014 |
| 24964988 | Comment on "CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy". | Science Translational Medicine | 2014 |
| 23069871 | Peripheral CD8(+) T cell proliferation is prognostic for patients with advanced thoracic malignancies. | Cancer Immunology, Immunotherapy | 2013 |
| 22071974 | Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates. | Gene Ther | 2012 |
| 22910319 | Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies. | British Journal of Cancer | 2012 |
| 23170256 | Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity. | Oncoimmunology | 2012 |
| 22048172 | Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. | Human Vaccines | 2011 |
| 21174144 | H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses. | Journal of Clinical Immunology | 2011 |
| 20554798 | Age-dependent differences in the pathogenesis of bovine respiratory syncytial virus infections related to the development of natural immunocompetence. | Journal of General Virology | 2010 |
| 19835828 | Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. | Vaccine | 2010 |
| 20513749 | Innate immunity defines the capacity of antiviral T cells to limit persistent infection. | Journal of Experimental Medicine | 2010 |
| 20007574 | Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation. | J Immunol | 2009 |
| 19052741 | Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. | Cancer Immunol Immunother | 2009 |
| 19746156 | Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growth. | PLoS One | 2009 |
| 19211743 | Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. | Journal of Virology | 2009 |
| 19380767 | Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy. | J Immunol | 2009 |